Search Details

Word: biotech (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

After Dhirubhai died in July 2002, his sons, Mukesh and Anil (estimated combined net worth: $2.8 billion), took control. They have been on an expansion tear ever since, successfully bolstering Reliance's presence in power generation, oil exploration, finance and biotech, and consolidating the company's position as a leading player in India's fast-growing telecom sector. With revenues of $16.8 billion, Reliance last year accounted for 3.5% of India's GDP. So confident are Indians in the firm's future that 1 out of every 4 stock-owning citizens hold Reliance shares...

Author: /time Magazine | Title: Ambani | 4/19/2004 | See Source »

...donors in the U.S. may leave their bodies to science, and while most people like to think of their mortal remains being gently dissected by respectful medical students, the fact is that cadavers might just as easily be sawed apart and scattered to pharmaceutical companies and biotech firms, or even used as flesh-and-blood crash-test dummies. The only hard rule, by federal law, is that under no circumstances may anyone profit from the transaction. The exception to that rule, however, is that the people handling, storing and processing the body may collect a reasonable fee for expenses. Such...

Author: /time Magazine | Title: The Body Snatchers | 3/22/2004 | See Source »

GORDON CAMERON Biotech Baron...

Author: /time Magazine | Title: People to Watch in International Business | 3/22/2004 | See Source »

...Growing Pains The British government gave the go-ahead for the commercial farming of genetically modified maize, the first biotech crop to be grown in the U.K. Anti-GM activists are threatening to rip the crops from the ground...

Author: /time Magazine | Title: Biz Watch | 3/14/2004 | See Source »

Stewart did break the law; she was found guilty of conspiring with her former Merrill Lynch stockbroker, Peter Bacanovic, for hiding the reason behind her Dec. 27, 2001 sale of shares in the biotech company ImClone Systems. The judge threw out the most serious charge against her—securities fraud, and prosecutors did not have evidence of insider trading and could not bring that charge against her. Stewart’s savings on the ImClone shares, sold the day before an announcement that sent the stock tumbling, was relatively small by corporate scandal standards, amounting to approximately...

Author: By Lia C. Larson, SKIRTING CONVENTION | Title: Martha Stewart's Recipe for Failure | 3/12/2004 | See Source »

Previous | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | Next